{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04355832",
            "orgStudyIdInfo": {
                "id": "HP-00090856"
            },
            "organization": {
                "fullName": "University of Maryland, Baltimore",
                "class": "OTHER"
            },
            "briefTitle": "Glucagon-like Peptide-1 in Type 1 Diabetes",
            "officialTitle": "Reducing Hypoglycemic, Pro-coagulant and Pro-atherothrombotic Responses and Preventing Hypoglycemia Associated Autonomic Failure in Type 1 DM. The Effects of Glucagon-like Peptide-1",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "glucagon-like-peptide-in-type-diabetes"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-06-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-04-17",
            "studyFirstSubmitQcDate": "2020-04-17",
            "studyFirstPostDateStruct": {
                "date": "2020-04-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-11",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Stephen N. Davis, MBBS",
                "investigatorTitle": "Professor",
                "investigatorAffiliation": "University of Maryland, Baltimore"
            },
            "leadSponsor": {
                "name": "University of Maryland, Baltimore",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The hypotheses to be tested in this application is: GLP-1 will acutely protect arterial endothelial function and reduce pro-atherothrombotic and pro-coagulant effects of repeated hypoglycemia in T1DM.",
            "detailedDescription": "The naturally occurring hormone GLP-1 when co-administered during hypoglycemia (low blood sugar) in non-diabetic individuals can reduce the deleterious effects of hypoglycemia on the vasculature. We have shown that IV infusion of GLP-1 during a single moderate episode of hypoglycemia can preserve endothelial function and protect the vasculature from pro-coagulant and pro-inflammatory effects in healthy individuals.\n\nIt is unknown whether GLP-1 could protect the vasculature during episodes of repeated hypoglycemia and whether GLP-1 would have protective effects in T1DM individuals."
        },
        "conditionsModule": {
            "conditions": [
                "Type1 Diabetes Mellitus"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Placebo 1",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "The participants will be randomized to placebo infusion.",
                    "interventionNames": [
                        "Drug: Placebos"
                    ]
                },
                {
                    "label": "Placebo 2",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "The participants will be randomized to placebo infusion.",
                    "interventionNames": [
                        "Drug: Placebos"
                    ]
                },
                {
                    "label": "GLP-1",
                    "type": "EXPERIMENTAL",
                    "description": "The participants will be randomized to Glucagon-like peptide-1 infusion.",
                    "interventionNames": [
                        "Drug: Glucagon-like peptide-1"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Glucagon-like peptide-1",
                    "description": "Infusion of Glucagon-like peptide-1",
                    "armGroupLabels": [
                        "GLP-1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebos",
                    "description": "Infusion of normal saline solution that will mimic Glucagon-like peptide-1",
                    "armGroupLabels": [
                        "Placebo 1",
                        "Placebo 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in the level of catecholamines in plasma",
                    "timeFrame": "3 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* 40 (20 males, 20 females) individuals with type 1 diabetes aged 18-50 yr.\n* HbA1c \\< 11.0%\n* Body mass index \\< 40kg \u2022 m-2\n* No clinically diagnosed diabetic tissue complications (i.e. history of retinopathy, neuropathy, stasis ulcers, etc)\n\nExclusion Criteria:\n\n* Subjects unable to give voluntary informed consent\n* Pregnancy\n* Subjects on anticoagulant drugs, anemic or with known bleeding diatheses\n* Subjects taking any of the following medications will be excluded: non-selective beta blockers,\n* sedative-hypnotics, anticonvulsants, antiparkinsonian drugs, antipsychotics, antidepressants,\n* mood stabilizers, CNS stimulants, opioids, hallucinogens\n* Subjects unwillingness or inability to comply with approved contraception measures\n* Subjects with a history of severe uncontrolled hypertension (i.e., blood pressure greater than 160/100), heart disease, cerebrovascular incidents\n* Clinically significant cardiac abnormalities (e.g. heart failure, arrhythmias, ischemic tachycardia, S-T segment deviations, etc.) from history or from cardiac stress testing in subjects \u2265 40 years old.\n* Pneumonia\n* Hepatic failure /jaundice\n* Abnormal results following screening tests and physical examination that are clinically significant\n* Acute cerebrovascular/ neurological deficit\n* Fever greater than 38.0 C\n* Screening Laboratory Tests Exclusion Criteria\n* Hematocrit lower than 32\n* WBC lower than 3 thou/ul or greater than 14 thou/ul\n* Liver function tests: SGOT and SGPT greater than twice upper limit of normal range (i.e. \\> 80 U/L)\n* TBil \\> 2 mg/dl\n* Creatinine \\> 1.6 mg/dl\n* Alkaline phosphatase \\> 150U/L\n* Hepatic transaminase \\> 2x normal",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "50 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Maka Siamashvili, MD",
                    "role": "CONTACT",
                    "phone": "410-706-5623",
                    "email": "msiamashvili@som.umaryland.edu"
                },
                {
                    "name": "Stephen N Davis, MBBS",
                    "role": "CONTACT"
                }
            ],
            "locations": [
                {
                    "facility": "University of Maryland",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Maka Siamashvili, MD",
                            "role": "CONTACT",
                            "phone": "615-715-9494",
                            "email": "msiamashvili@som.umaryland.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003922",
                    "term": "Diabetes Mellitus, Type 1"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7117",
                    "name": "Diabetes Mellitus, Type 1",
                    "asFound": "Type 1 Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M10053",
                    "name": "Hypoglycemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M27980",
                    "name": "Pure Autonomic Failure",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4832",
                    "name": "Pure Autonomic Failure",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005934",
                    "term": "Glucagon"
                },
                {
                    "id": "D000052216",
                    "term": "Glucagon-Like Peptide 1"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000054795",
                    "term": "Incretins"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9043",
                    "name": "Glucagon",
                    "asFound": "Before surgery",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26997",
                    "name": "Glucagon-Like Peptide 1",
                    "asFound": "Natural Killer Cells",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M6259",
                    "name": "Coagulants",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M27905",
                    "name": "Incretins",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "Coag",
                    "name": "Coagulants"
                }
            ]
        }
    },
    "hasResults": false
}